Daily use of lozenge containing arginine and probiotics may benefit children with dental caries

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-08-10 14:30 GMT   |   Update On 2023-08-10 14:36 GMT

Daily use of lozenge containing arginine and probiotics may benefit children with dental caries suggests a new study published in the Journal of Dentistry.A study was done to investigate the effect of daily use of a lozenge containing arginine and probiotics for 10–12 months on caries increment, gingivitis- and plaque occurrence in children aged 5–9 years.In this...

Login or Register to read the full article

Daily use of lozenge containing arginine and probiotics may benefit children with dental caries suggests a new study published in the Journal of Dentistry.

A study was done to investigate the effect of daily use of a lozenge containing arginine and probiotics for 10–12 months on caries increment, gingivitis- and plaque occurrence in children aged 5–9 years.
In this placebo-controlled, double-blinded, parallel-grouped randomized clinical trial, 343 children were randomly assigned to one of the study arms (1:1). The intervention group (n = 172) received a lozenge containing Lacticaseibacillus rhamnosus, LGG® (DSM33156), Lactobacillus paracasei subsp. paracasei, L. CASEI 431® (DSM33451) and prebiotic (arginine 2%). The placebo group (n = 171) received an identical lozenge without arginine or probiotics. Primary canines and molars, and permanent first molars were examined clinically (d/D= ICDAS1–6) and radiographically (d/D = R1–6) at baseline and follow-up. Missing (m/M), sealed (s/S), and filled (f/F) surfaces (-s/-S) in both dentitions were also included. Utilizing clinical and radiographic scorings, caries experience was classified as dICDAS1–6msf-s (primary teeth), DICDAS1–6MSF-S (permanent teeth), d/DICDAS1–6 m/M-s/S-f/F-s/S (mixed dentition). A weighted and an unweighted score system was applied.

Results

The study was completed by 288 children. The dropout rate was 15%. The increase in ∆mean dICDAS3–6msf-s and ∆mean d/DICDAS3–6m/M-s/S-f/F-s/S was lower in the intervention group (p = 0.007). No differences were found for gingivitis- and plaque occurrence. No product-related side effects were reported. This study followed ICH-GCP including external monitoring.

Daily consumption of a lozenge containing prebiotic arginine and two strains of probiotics showed safe use and statistically significantly reduction in caries incrementbut no effect on the mean plaque or gingivitis occurrence in children. The use of a lozenge with arginine and probiotics combined has a promising potential as a supplementary tool for future management of caries.

The combination of prebiotic arginine and probiotics shows clinical potential as a supplementary approach to toothbrushing with fluoride toothpaste in managing caries increment in children. A new era in the management of caries may be emerging.

Keywords: Randomized clinical trial; Caries; Probiotics; Arginine; Synbiotic; Pediatric dentistry

Reference:

Camilla Juhl Pørksen, Mette Kirstine Keller, Anders Damholt, Amalie Kruse Sigersted Frederiksen, Kim Rud Ekstrand, Merete Markvart, Tove Larsen, Azam Bakhshandeh,

The effect of a lozenge combining prebiotic arginine and probiotics on caries increment in children during 10–12 months, a randomized clinical trial, Journal of Dentistry, Volume 135,

2023, 104599, ISSN 0300-5712. https://doi.org/10.1016/j.jdent.2023.104599.

Keywords:

Daily, use, lozenge, containing, arginine, probiotics, may, benefit, children, with, dental, caries, Camilla Juhl Pørksen, Mette Kirstine Keller, Anders Damholt, Amalie Kruse Sigersted Frederiksen, Kim Rud Ekstrand, Merete Markvart, Tove Larsen, Azam Bakhshandeh, Journal of Dentistry

Tags:    
Article Source : Journal of Dentistry

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News